FDA Investigator Gloria E Parra
Gloria E Parra has conducted inspections on 8 sites in 3 countries as of 27 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
27 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Switzerland,
United States of America,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Gloria E Parra:
Alia Legaux,
Amy Wyan Mai,
Anita Narula, PhD,
Ariel Cruz Figueroa,
Arsen Karapetyan,
Barbara M Frazier,
Burnell M Henry,
Chikako Torigoe, PhD,
Christian D Lynch (CDL),
Craig A Garmendia,
Donald J Ullstrom,
Dr. Gang Wang, PhD,
Edwin Melendez,
Esteban Beltran,
Evelyn Taha,
Gary T Greco,
Gene D Arcy,
George Pyramides,
Hasan A Irier, PhD,
Haydee B Romero,
Holly Brevig,
Irina Gaberman,
Jacqueline Mdiaz Albertini,
Jagdish R Amin,
James A Liubicich,
James L Dunnie, Jr,
Jason K Morgan,
Jessica M Monteiro,
Jose A Lopez,
Jose Acruz Gonzalez,
Junho Pak,
Larry K Austin,
Laura M Howard,
Laura Schankweiler,
Leena Thomas,
Li Hongpaul Yeh, PhD,
Lisa Mathew,
LTJG Matthew R Palo,
Matthew A Spataro,
Melissa D Ray,
Mercy O Quagraine,
Michael A Charles,
Michael E Maselli,
Michael R Dominick,
Michael R Goga,
Michelle Yclark Stuart,
Mohammad Heidaran, PhD,
Mohsen Rajabi Abhari, FDA,
Mra Mcculloughj,
Niketa Patel,
Parul M Patel,
Patricia F Hughes, PhD,
Patrick L Wisor,
Peter Abel,
Prabhu P Raju,
Rebecca E Dombrowski,
Reyes Candau Chacon, PhD,
Samina S Khan,
Sandra D Thompson,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Steven M Weinman,
Tawny L Colling,
Thomas J Arista,
Thomas W Nojek,
Thuy T Nguyen, LCDR,
Tina M Pawlowski,
Torrance J Slayton,
Uduak M Inokon,
Valerie Jgrecek Trinh,
Wayne E Seifert,
Xianghong Jing (Emily), PhD,
Yumi J Hiramine
Gloria E Parra's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2001 | EIR | New York Blood Center, Inc. - EIR, 2001-05-21 |
September, 2002 | EIR | Pfizer, Inc. - EIR, 2002-09-27 |
November, 2003 | FDA 483 | Norton Healthcare Limited - Form 483, 2003-11-04 |
May, 2001 | FDA 483 Response | New York Blood Center, Inc. - Form 483R, 2001-08-15 |
May, 2001 | FDA 483 | New York Blood Center, Inc. - Form 483, 2001-05-21 |
November, 2002 | EIR | Senn Chemicals AG - EIR, 2002-11-21 |
November, 2002 | FDA 483 Response | Senn Chemicals AG - Form 483R, 2002-12-20 |
November, 2002 | FDA 483 | Senn Chemicals AG - Form 483, 2002-11-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more